作为抗癌药物的5-氟脲嘧啶衍生物的发展

2012-03-31 20:05 来源:丁香园 作者:西安交通大学医学院
字体大小
- | +

Curr Med Chem 2011 Oct;18 (29): 4538-56. [IF:4.630]
Development of 5-Fluorouracil derivatives as anticancer agents.
Pan X , Wang C , Wang F , Li P , Hu Z , Shan Y , Zhang J .
School of Medicine, Xi'an Jiaotong University, No. 76, Yanta West Road, 710061, Xi'an, Shaanxi Province, P.R. China. zhj8623@mail.xjtu.edu.cn.
西安交通大学医学院

Abstract
5-Fluorouracil (5-FU) is one of the most potent antimetabolites which have been widely used in the treatment of advanced solid tumors. As an anticancer agent, because of its low efficacy and high toxicity, numerous modifications of 5-FU structure have been performed. A great number of novel 5-FU derivatives have been developed with highly efficient and much less toxic. In this paper, the recent development of novel 5-FU derivatives as potent antitumor agents is reviewed and discussed.

编辑: lizexiu

版权声明

本网站所有注明“来源:丁香园”的文字、图片和音视频资料,版权均属于丁香园所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明“来源:丁香园”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。同时转载内容不代表本站立场。